MPM Oncology Innovations Fund GP LLC, 10% Owner at Werewolf Therapeutics, Inc. (HOWL), sold 348,799 shares at $0.92 ($320K) on 2025-11-25, disclosed to the SEC on 2025-11-25.
Scheduled sale ($320k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.83 | 64,331 | $53K | 16.7% |
| 2 | $0.83 | 64,331 | $53K | 16.7% |
| 3 | $0.98 | 88,802 | $87K | 27.2% |
| 4 | $0.98 | 88,802 | $87K | 27.2% |
| 5 | $0.92 | 42,533 | $39K | 12.2% |
| Total | $0.92 avg | 348,799 |
| $320K |
| 100% |
| Filing → |